- CEO
- Fei Pu
- Full Time Employees
- 8,689
- Sector
- Health technology
- Industry
- Medical specialties
- Address
- 37 Chaoqian Road Beijing BE China 102200
- IPO Date
- Nov 3, 2009
- Business
- Lepu Medical Technology (Beijing) Co., Ltd. specializes in the development, manufacturing, and marketing of high-tech medical devices and equipment with a focus on cardiovascular interventions, structural heart diseases, cardiac rhythm management, anesthesia and critical care, in vitro diagnostics, and general surgery. Its product portfolio includes coronary stents, balloon catheters, guide wires, introducer sheaths, fractional flow reserve systems, mechanical heart valves, pacemakers, electrophysiology catheters, digital subtraction angiography (DSA) systems, surgical staplers, ultrasound systems, hemodialysis products, home medical devices such as oxygen generators and nebulizers, oncology diagnostics, orthopedic products, and related accessories. The company also markets active pharmaceutical ingredients and formulations for cardiovascular diseases, oncology, anti-infectives, and the central nervous system. Lepu serves healthcare providers globally with operations that extend beyond China. Founded in 1999 and headquartered in Beijing, China, Lepu Medical Technology is recognized as a leading player in China’s medical technology industry.
Recent major changes include accelerated development and commercialization efforts in structural heart disease devices, including transcatheter aortic valve systems and mitral valve repair systems, alongside the advancement of neurostimulation systems and renal artery ablation catheters entering clinical trials. The company has focused on innovation through new product launches such as its AI-driven tablet patient monitor and iterations of digital health and hospital network management solutions. It has also adjusted its financial reporting standards and strengthened its product pipeline with bioresorbable coronary scaffolds and advanced cardiovascular artificial intelligence systems. Lepu continues to expand strategic efforts in global markets and enhance its capabilities in in vitro diagnostics and interventional products. These developments reflect its strategic priority on product innovation, healthcare service expansion, and international growth.